Australian Court Bars Ranbaxy’s Generic Lipitor
Pfizer said Tuesday the federal court in Victoria has affirmed the patent for the ingredient atorvastatin and issued an injunction against the Indian company’s generic version of the drug.
The court allowed Pfizer’s patent to hold on to its exclusivity in Australia until the end of May 2012. Ranbaxy, which filed the suit disputing Pfizer’s...
To view the full article, register now.